Yen and Jaffe's Reproductive Endocrinology 2019
DOI: 10.1016/b978-0-323-47912-7.00033-0
|View full text |Cite
|
Sign up to set email alerts
|

Fertility Preservation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 272 publications
0
3
0
Order By: Relevance
“…Innovative methods to restore fertility and hormone production are needed to bridge this clinical gap. An engineered tissue, such as a patient-specific organoid capable of producing gametes ex vivo, or amenable to hormone restoration when used as a transplantable bioprosthetic, could one day serve this purpose [35][36][37]. Furthermore, organoids enable the observation of testicular tubule assembly and cell-cell interactions in a higherthroughput and more accessible way than in vivo mouse models, enabling the in-depth study of normal physiology and pathological states of infertility [6,7].…”
Section: Introductionmentioning
confidence: 99%
“…Innovative methods to restore fertility and hormone production are needed to bridge this clinical gap. An engineered tissue, such as a patient-specific organoid capable of producing gametes ex vivo, or amenable to hormone restoration when used as a transplantable bioprosthetic, could one day serve this purpose [35][36][37]. Furthermore, organoids enable the observation of testicular tubule assembly and cell-cell interactions in a higherthroughput and more accessible way than in vivo mouse models, enabling the in-depth study of normal physiology and pathological states of infertility [6,7].…”
Section: Introductionmentioning
confidence: 99%
“…Fertility preservation through OTC is a powerful technique for preserving female reproductive potential; it can preserve thousands of ovarian follicles at once and simultaneously restore endocrine function and fertility, thus allowing spontaneous conception [ 5 , 6 ] and is the only option for prepubertal girls and women who cannot delay the start of oncological treatments [ 7 ]. According to the American Society for Reproductive Medicine (ASRM), this approach is no longer considered experimental [ 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…According to the American Society for Reproductive Medicine (ASRM), this approach is no longer considered experimental [ 6 ]. However, there are some concerns about the graft’s survival after transplantation and the potential risk of reimplantation of tumour cells [ 5 , 6 ]. Therefore, many studies are underway to overcome these limitations and new and experimental techniques have been developed, such as in vitro maturation [ 8 – 10 ].…”
Section: Introductionmentioning
confidence: 99%